Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo

Delivery of RNA Nanoparticles into Colorectal Cancer Metastases Following Systemic Administration

(2015) Piotr Rychahou et al.   ACS Nano

Antibody-Mediated Delivery of Anti-KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer

(2015) S. Baumer et al.   CLINICAL CANCER RESEARCH

Stable RNA nanoparticles as potential new generation drugs for cancer therapy

(2013) Yi Shu et al.   ADVANCED DRUG DELIVERY REVIEWS

The E5 proteins

(2013) Daniel DiMaio et al.   VIROLOGY

Enhanced specificity of HPV16 E6E7 siRNA by RNA–DNA chimera modification

(2011) K Yamato et al.   CANCER GENE THERAPY

The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo

(2011) Hun Soon Jung et al.   INTERNATIONAL JOURNAL OF CANCER

Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics

(2011) Dan Shu et al.   Nature Nanotechnology

A Role for HPV16 E5 in Cervical Carcinogenesis

(2010) John P. Maufort et al.   CANCER RESEARCH

Carboplatin and Paclitaxel in Metastatic or Recurrent Cervical Cancer

(2010) Dimitrios Pectasides et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer

(2008) Hirohisa Tsukamoto et al.   BMC CANCER

Chemical Modification of siRNAs for In Vivo Use

(2008) Mark A. Behlke   OLIGONUCLEOTIDES